Table 1 Baseline characteristics of study patients for peritoneal dialysis.
Variables | All (N = 1730)(%) | Non-survivor (N = 343)(%) | Survivor (N = 1387)(%) | P |
|---|---|---|---|---|
Age (years) | 52.7 ± 12.6 | 62.3 ± 10.8 | 50.3 ± 11.8 | <0.001 |
Sex (male) | 991 (57.3) | 217 (63.3) | 774 (55.8) | 0.012 |
BMI (kg/m2) | 23.3 ± 3.2 | 23.5 ± 3.2 | 23.2 ± 3.2 | 0.133 |
Primary renal disease | <0.001 | |||
Diabetes | 617 (35.7) | 179 (52.2) | 438 (31.6) | |
Hypertension | 382 (22.1) | 61 (17.8) | 321 (23.1) | |
Glomerulonephritis | 292 (16.9) | 30 (8.7) | 262 (18.9) | |
Cystic kidney disease | 32 (1.8) | 6 (1.7) | 26 (1.9) | |
Unknown | 117 (6.8) | 29 (8.5) | 88 (6.3) | |
Others | 290 (16.8) | 38 (11.1) | 252 (18.2) | |
History of CVD | 461 (26.6) | 149 (43.4) | 312 (22.5) | <0.001 |
History of DM | 712 (41.2) | 209 (60.9) | 503(36.3) | <0.001 |
Dialysis duration (months) | 59.1 ± 46.3 | 59.9 ± 46.2 | 58.9 ± 46.3 | 0.727 |
Smoking history (%) | 151 (8.7) | 18 (5.2) | 133 (9.6) | 0.011 |
Modified CCI | 4.4 ± 2.0 | 5.9 ± 2.0 | 4.0 ± 1.8 | <0.001 |
Use of RAAS blockade | 963 (55.7) | 191 (55.7) | 772 (55.7) | 0.993 |
Systolic BP (mmHg) | 133 ± 21 | 132 ± 21 | 134 ± 21 | 0.134 |
Diastolic BP (mmHg) | 79 ± 22 | 76 ± 13 | 80 ± 23 | 0.005 |
Laboratory findings at dialysis initiation | ||||
Hemoglobin (g/dL) | 10.1 ± 3.4 | 10.3 ± 1.5 | 10.1 ± 3.7 | 0.344 |
BUN | 64.5 ± 31.3 | 55.8 ± 28.7 | 66.5 ± 31.6 | <0.001 |
Creatinine | 8.9 ± 4.5 | 7.7 ± 3.9 | 9.1 ± 4.5 | <0.001 |
Calcium | 8.4 ± 0.9 | 8.5 ± 0.9 | 8.3 ± 1.0 | 0.070 |
Phosphorus | 5.2 ± 1.6 | 4.7 ± 1.5 | 5.3 ± 1.6 | <0.001 |
Uric acid | 7.4 ± 2.0 | 7.0 ± 1.9 | 7.5 ± 2.0 | <0.001 |
Total cholesterol | 171 ± 44 | 168 ± 43 | 172 ± 44 | 0.195 |
Albumin | 3.69 ± 2.19 | 3.67 ± 3.43 | 3.69 ± 1.79 | 0.908 |
Intact-PTH | 290.6 ± 297.7 | 247.8 ± 282.1 | 300.8 ± 300.3 | 0.016 |
β2-microglobulin | 51.2 ± 82.3 | 48.9 ± 70.6 | 51.8 ± 85.3 | 0.697 |
